Evidence map›Paper›PMID 31883096›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2020

Metabolite, Protein, and Lipid Extraction (MPLEx): A Method that Simultaneously Inactivates Middle East Respiratory Syndrome Coronavirus and Allows Analysis of Multiple Host Cell Components Following Infection.

Carrie D Nicora, Amy C Sims, Kent J Bloodsworth, Young-Mo Kim, Ronald J Moore, Jennifer E Kyle, Ernesto S Nakayasu, Thomas O Metz

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. The role of lipids in the pathophysiology of coronavirus infections.Osong public health and research perspectives · 2021
    Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carrie D NicoraBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Amy C SimsDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kent J BloodsworthBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Young-Mo KimBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Ronald J MooreBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Jennifer E KyleBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Ernesto S NakayasuBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
Thomas O MetzBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. Thomas.metz@pnnl.gov.

Funding

Systems Biology Identifies Restriction Factors for West Nile VirusU19AI106772 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LIVNY, MIRON · 2013 to 2017
$26.1M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
NIAID NIH HHS U19 AI106772NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

Mass spectrometry (MS)-based, integrated proteomics, metabolomics, and lipidomics (collectively, multi-omics) studies provide a very detailed snapshot of virus-induced changes to the host following infection and can lead to the identification of novel prophylactic and therapeutic targets for preventing or lessening disease severity. Multi-omics studies with Middle East respiratory syndrome coronavirus (MERS-CoV) are challenging as the requirements of biosafety level 3 containment limit the numbers of samples that can be safely managed. To address these issues, the multi-omics sample preparation technique MPLEx (metabolite, protein, and lipid extraction) was developed to partition a single sample into three distinct parts (metabolites, proteins, and lipids) for multi-omics analysis, while simultaneously inactivating MERS-CoV by solubilizing and disrupting the viral envelope and denaturing viral proteins. Here we describe the MPLEx protocol, highlight the step of inactivation, and describe the details of downstream processing, instrumental analysis of the three separate analytes, and their subsequent informatics pipelines.

Indexed as

Host-Pathogen InteractionsMetabolomicsProteomicsCoronavirus InfectionsHumansLipidsMass SpectrometryMiddle East Respiratory Syndrome CoronavirusVirus InactivationLipidsLipidomicsMass spectrometry (MS)MERS-CoVMetabolomicsMPLExProteomicsVirus-host interactionsVirus inactivation

Identifiers

PMID31883096
PMCPMC7121680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.